JP2022534302A5 - - Google Patents

Info

Publication number
JP2022534302A5
JP2022534302A5 JP2021570919A JP2021570919A JP2022534302A5 JP 2022534302 A5 JP2022534302 A5 JP 2022534302A5 JP 2021570919 A JP2021570919 A JP 2021570919A JP 2021570919 A JP2021570919 A JP 2021570919A JP 2022534302 A5 JP2022534302 A5 JP 2022534302A5
Authority
JP
Japan
Prior art keywords
ethynyl
pyrimidine
phenyl
hydroxy
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021570919A
Other languages
English (en)
Japanese (ja)
Other versions
JP7547387B2 (ja
JP2022534302A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/065024 external-priority patent/WO2020239999A1/en
Publication of JP2022534302A publication Critical patent/JP2022534302A/ja
Publication of JP2022534302A5 publication Critical patent/JP2022534302A5/ja
Priority to JP2024146717A priority Critical patent/JP7872322B2/ja
Application granted granted Critical
Publication of JP7547387B2 publication Critical patent/JP7547387B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021570919A 2019-05-31 2020-05-29 NF-κB誘導キナーゼの低分子阻害剤 Active JP7547387B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024146717A JP7872322B2 (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962855144P 2019-05-31 2019-05-31
US62/855,144 2019-05-31
US201962907833P 2019-09-30 2019-09-30
US62/907,833 2019-09-30
PCT/EP2020/065024 WO2020239999A1 (en) 2019-05-31 2020-05-29 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024146717A Division JP7872322B2 (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Publications (3)

Publication Number Publication Date
JP2022534302A JP2022534302A (ja) 2022-07-28
JP2022534302A5 true JP2022534302A5 (enExample) 2023-06-05
JP7547387B2 JP7547387B2 (ja) 2024-09-09

Family

ID=71108552

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021570919A Active JP7547387B2 (ja) 2019-05-31 2020-05-29 NF-κB誘導キナーゼの低分子阻害剤
JP2024146717A Active JP7872322B2 (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024146717A Active JP7872322B2 (ja) 2019-05-31 2024-08-28 NF-κB誘導キナーゼの低分子阻害剤

Country Status (37)

Country Link
US (3) US11254673B2 (enExample)
EP (2) EP4467199A3 (enExample)
JP (2) JP7547387B2 (enExample)
KR (1) KR102995125B1 (enExample)
CN (2) CN114222737B (enExample)
AU (1) AU2020282005B2 (enExample)
BR (1) BR112021023796A2 (enExample)
CL (1) CL2021003142A1 (enExample)
CO (1) CO2021017838A2 (enExample)
CR (1) CR20210587A (enExample)
DK (1) DK3976597T3 (enExample)
DO (1) DOP2021000244A (enExample)
EC (1) ECSP21093623A (enExample)
ES (1) ES2989387T3 (enExample)
FI (1) FI3976597T3 (enExample)
HR (1) HRP20241352T1 (enExample)
HU (1) HUE068694T2 (enExample)
IL (1) IL288387B2 (enExample)
JO (1) JOP20210318B1 (enExample)
LT (1) LT3976597T (enExample)
MA (1) MA56038B1 (enExample)
MD (1) MD3976597T2 (enExample)
MX (1) MX2021014679A (enExample)
MY (1) MY205653A (enExample)
PE (1) PE20220768A1 (enExample)
PH (1) PH12021553011A1 (enExample)
PL (1) PL3976597T3 (enExample)
PT (1) PT3976597T (enExample)
RS (1) RS66105B1 (enExample)
SA (1) SA521430960B1 (enExample)
SG (1) SG11202112994WA (enExample)
SI (1) SI3976597T1 (enExample)
SM (1) SMT202400418T1 (enExample)
TW (2) TWI906955B (enExample)
UA (1) UA130430C2 (enExample)
UY (1) UY38721A (enExample)
WO (1) WO2020239999A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11458149B1 (en) 2019-05-31 2022-10-04 Ikena Oncology, Inc. TEAD inhibitors and uses thereof
BR112021024108A2 (pt) 2019-05-31 2022-03-22 Ikena Oncology Inc Inibidores de tead e usos dos mesmos
CR20210587A (es) * 2019-05-31 2022-02-11 Janssen Pharmaceutica Nv Inhibidores de molécula pequeña de quinasa inductora de nf-kb
CA3257152A1 (en) * 2022-05-11 2023-11-16 Janssen Pharmaceutica Nv Pyrrolidine derivatives useful as NF-κB induction kinase inhibitors
JP2025516559A (ja) * 2022-05-11 2025-05-30 ヤンセン ファーマシューティカ エヌ.ベー. Nf-カッパb誘導性キナーゼの阻害剤としてのピロリジオン(pyrrolidione)誘導体
AU2023410324A1 (en) 2022-12-22 2025-05-15 Boehringer Ingelheim International Gmbh Crystalline forms of a her2 inhibitor
WO2025020886A1 (zh) * 2023-07-27 2025-01-30 浙江星浩澎博医药有限公司 氮杂喹唑啉环衍生物及其用途
CN121568696A (zh) 2023-07-28 2026-02-24 勃林格殷格翰国际有限公司 制备her2抑制剂的方法
WO2025235874A1 (en) * 2024-05-10 2025-11-13 Schrödinger, Inc. Heterocyclics as egfr inhibitors
WO2026029041A1 (ja) * 2024-07-30 2026-02-05 日本たばこ産業株式会社 ピラゾロピリミジン化合物及びその医薬用途

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9930616D0 (en) 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
US7132428B2 (en) 2003-07-03 2006-11-07 Aventis Pharmaceuticals Inc. Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
JP4828421B2 (ja) 2003-08-14 2011-11-30 アレイ バイオファーマ、インコーポレイテッド 受容体チロシンキナーゼ阻害剤としてのキナゾリン誘導体
MXPA06011423A (es) 2004-04-02 2007-01-23 Osi Pharm Inc Inhibidores de proteina cinasa heterobiciclica sustituida en el anillo 6,6-biciclico.
GT200500208A (es) * 2004-08-03 2006-03-02 Indazoles ùtiles para tratar enfermedades cardiovasculares
JP2008519850A (ja) 2004-11-10 2008-06-12 シンタ ファーマシューティカルズ コーポレーション Il−12調節化合物
TWI368974B (en) 2004-11-12 2012-07-21 Chippac Inc Ball-on-trace wire bond interconnection
AU2009263037B2 (en) * 2008-06-26 2011-10-06 Amgen Inc. Alkynyl alcohols as kinase inhibitors
WO2010042337A1 (en) 2008-10-07 2010-04-15 Merck Sharp & Dohme Corp. Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
AR085908A1 (es) * 2011-03-16 2013-11-06 Hoffmann La Roche DERIVADOS DE 3-BUTIN-2-OL Y DE CARBONITRILO CON ACTIVIDAD INHIBIDORA DE LA QUINASA INDUCTORA DE NF-kB (NIK)
AR089999A1 (es) * 2012-02-17 2014-10-01 Hoffmann La Roche Compuestos triciclicos y metodos para el uso de los mismos
US9159402B2 (en) 2012-07-02 2015-10-13 Stmicroelectronics International N.V. SRAM bitcell implemented in double gate technology
US8859553B2 (en) * 2012-07-30 2014-10-14 Astar Biotech Llc Protein kinase inhibitors
BR112015010225A2 (pt) 2012-11-05 2017-07-11 Zafgen Inc compostos tricíclicos e seus métodos de produção e utilização
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
JP2016533385A (ja) * 2013-08-22 2016-10-27 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft アルキニルアルコール及び使用方法
WO2015025026A1 (en) * 2013-08-22 2015-02-26 F. Hoffmann-La Roche Ag Alkynyl alcohols and methods of use
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
EP4649963A3 (en) 2014-04-14 2026-05-13 Arvinas Operations, Inc. Imide-based modulators of proteolysis and associated methods of use
WO2016062792A1 (en) 2014-10-23 2016-04-28 Janssen Pharmaceutica Nv New compounds as nik inhibitors
AU2015334914B2 (en) 2014-10-23 2019-09-19 Janssen Pharmaceutica Nv New thienopyrimidine derivatives as NIK inhibitors
JP6616411B2 (ja) 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ.ベー. 新規な、nik阻害剤としてのピラゾール誘導体
EA033237B1 (ru) 2014-10-23 2019-09-30 Янссен Фармацевтика Нв Новые производные пиразолопиримидина в качестве ингибиторов nik, фармацевтическая композиция и лекарственное средство, содержащее ее
WO2016135163A1 (en) 2015-02-25 2016-09-01 F. Hoffmann-La Roche Ag Alkynyl alcohols and methods of use
EP3405464B1 (en) 2016-01-22 2019-12-04 Janssen Pharmaceutica NV New 6-membered heteroaromatic substituted cyanoindoline derivatives as nik inhibitors
HRP20200133T1 (hr) 2016-01-22 2020-05-15 Janssen Pharmaceutica Nv Novi supstituirani derivati cijanoindolina kao inhibitori nik
EP3478675B1 (en) 2016-06-30 2020-04-22 Janssen Pharmaceutica NV Heteroaromatic derivatives as nik inhibitors
WO2018002219A1 (en) 2016-06-30 2018-01-04 Janssen Pharmaceutica Nv Cyanoindoline derivatives as nik inhibitors
JP7140751B2 (ja) 2016-08-24 2022-09-21 エフ.ホフマン-ラ ロシュ アーゲー 2-アザビシクロ[3.1.0]ヘキサン-3-オン誘導体及び使用方法
CN109863142B (zh) * 2016-08-24 2022-06-10 豪夫迈·罗氏有限公司 2-氮杂双环[3.1.0]己烷-3-酮衍生物及使用方法
AU2018297592B2 (en) 2017-07-06 2021-12-16 Janssen Pharmaceutica Nv New substituted azaindoline derivatives as NIK inhibitors
CN109810110B (zh) * 2017-11-22 2023-01-24 中国科学院上海药物研究所 一种具有2-氨基嘧啶结构的化合物,其制备方法和用途
BR112021024108A2 (pt) 2019-05-31 2022-03-22 Ikena Oncology Inc Inibidores de tead e usos dos mesmos
CR20210587A (es) * 2019-05-31 2022-02-11 Janssen Pharmaceutica Nv Inhibidores de molécula pequeña de quinasa inductora de nf-kb
JP7670626B2 (ja) 2019-05-31 2025-04-30 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド及びその組成物
US11458149B1 (en) 2019-05-31 2022-10-04 Ikena Oncology, Inc. TEAD inhibitors and uses thereof
MA56022A (fr) 2019-05-31 2022-04-06 Chiesi Farm Spa Dérivés d'amino quinazoline servant d'inhibiteurs de p2x3
JP7559059B2 (ja) 2019-09-30 2024-10-01 インサイト・コーポレイション 免疫調節剤としてのピリド[3,2-d]ピリミジン化合物
JP2025516564A (ja) 2022-05-11 2025-05-30 ヤンセン ファーマシューティカ エヌ.ベー. NF-κB誘導性キナーゼの阻害剤としてのピロリジノン誘導体

Similar Documents

Publication Publication Date Title
RU2473549C2 (ru) Пиримидиновые соединения, композиции и способы применения
IL310992A (en) NLRP3 inhibitors
HRP20240994T1 (hr) Spoj inhibitora jak i njegova uporaba
JP2020531498A5 (enExample)
JP2022500402A5 (enExample)
CN118974055A (zh) 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途
JP2024532733A (ja) 複素環式化合物及び使用方法
US9108970B2 (en) Fused heteroaromatic pyrrolidinones
CN118715215A (zh) 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途
TWI766281B (zh) 作為jak1抑制劑之哌啶-4-基三亞甲亞胺衍生物
JP2020050682A (ja) ドライアイおよび他の目に関連する疾患を治療するためのヤヌスキナーゼ阻害剤
JP2016537384A5 (enExample)
US20130310340A1 (en) Method of treating muscular degradation
JP2013508404A5 (enExample)
JP2014527959A5 (enExample)
JP2020526549A5 (enExample)
JP2017518326A5 (enExample)
JP2018522859A5 (enExample)
HRP20170285T1 (hr) Heterociklilamini kao inhibitori pi3k
JP2018529731A5 (enExample)
JP2012527483A (ja) ヤヌスキナーゼ阻害剤としてのピラゾール−4−イル−ピロロ[2,3−d]ピリミジンおよびピロール−3−イル−ピロロ[2,3−d]ピリミジンのN−(ヘテロ)アリール−ピロリジン誘導体
RU2016140338A (ru) Азаспиро производные в качестве антагонистов trpm8
RU2008142832A (ru) Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1
RU2012139182A (ru) ПИРИДО[3,2-d]ПИРИМИДИНЫ - ИНГИБИТОРЫ PI3К ДЕЛЬТА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
ES2989387T3 (es) Pequeñas moléculas inhibidoras de la quinasa inductora de nf-kb